This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT-560

AbbVie Inc.

Drug Names(s): ABT 560

Description: ABT-560 is an alpha4beta2 neuronal nicotinic receptor (NNR) agonist.

Deal Structure: From 1999 to 2003 NeuroSearch and Abbott collaborated within the field of Neuronal Nicotine Acetycholine Receptors (NNRs). Abbott is responsible for clinical development and commercialization of all compounds emerging from the collaboration and will finance all development costs.

Partners: NeuroSearch A/S


ABT-560 News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug